↓ Skip to main content

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

Overview of attention for article published in BMC Cancer, September 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma
Published in
BMC Cancer, September 2022
DOI 10.1186/s12885-022-09723-w
Pubmed ID
Authors

Julia Wendler, Christopher P. Fox, Elke Valk, Cora Steinheber, Heidi Fricker, Lisa K. Isbell, Simone Neumaier, Jessica Okosun, Florian Scherer, Gabriele Ihorst, Kate Cwynarski, Elisabeth Schorb, Gerald Illerhaus

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 17%
Professor > Associate Professor 3 13%
Student > Bachelor 2 9%
Student > Ph. D. Student 2 9%
Unspecified 1 4%
Other 2 9%
Unknown 9 39%
Readers by discipline Count As %
Medicine and Dentistry 8 35%
Unspecified 1 4%
Nursing and Health Professions 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Psychology 1 4%
Other 1 4%
Unknown 10 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2022.
All research outputs
#14,003,371
of 24,417,958 outputs
Outputs from BMC Cancer
#2,950
of 8,667 outputs
Outputs of similar age
#168,205
of 421,332 outputs
Outputs of similar age from BMC Cancer
#32
of 219 outputs
Altmetric has tracked 24,417,958 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,667 research outputs from this source. They receive a mean Attention Score of 4.5. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,332 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 219 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.